Anne C. de Jong-Laird, MD
Otsuka Pharmaceutical Europe Ltd, Wexham, United Kingdom; Corresponding author: Anne C. de Jong-Laird, MD, Otsuka Pharmaceutical Europe Ltd, Gallions – 1st Floor, Wexham Springs, Framewood Rd, Wexham SL3 6PJ, United Kingdom ([email protected]).
Original Research
Aripiprazole Once Monthly in Recent-Onset Schizophrenia
September 30, 2021
This study compared time to discontinuation and clinical outcomes of aripiprazole once-monthly 400 mg versus oral atypical antipsychotics in patients with recent-onset schizophrenia in a naturalistic setting. Read on...
